Related Experiment Videos
Bone marrow transplantation for severe aplastic anemia in children: conditioning with cyclophosphamide and total
Insights
This study shows cyclophosphamide and total lymphoid irradiation enabled successful bone marrow transplants in children with severe aplastic anemia. A 75% survival rate was achieved, highlighting the regimen
Area of Science:
- Hematology
- Immunology
- Pediatric Oncology
Background:
- Severe aplastic anemia is a life-threatening condition requiring bone marrow transplantation.
- Previous blood transfusions can complicate engraftment due to donor sensitization.
Purpose of the Study:
- To evaluate the efficacy of cyclophosphamide and total lymphoid irradiation in pediatric severe aplastic anemia patients undergoing allogeneic bone marrow transplantation.
- To assess engraftment success and survival rates in this challenging patient population.
Main Methods:
- Four children with severe aplastic anemia received preparative regimens including cyclophosphamide and total lymphoid irradiation.
- Allogeneic bone marrow transplantation was performed.
- Engraftment and survival were monitored post-transplantation.
Main Results:
- Successful engraftment was achieved in all four children, despite prior exposure to multiple blood product transfusions.
- Three out of four children survived long-term (390, 540, and 1,235 days post-transplant).
- The one-year survival rate was 75%.
Conclusions:
- The combination of cyclophosphamide and total lymphoid irradiation is an effective preparative regimen for allogeneic bone marrow transplantation in children with severe aplastic anemia.
- Graft-versus-host disease and infections remain significant challenges requiring further management strategies.
Abstract:
We used preparative regimens consisting of cyclophosphamide and total lymphoid irradiation in 4 children with severe aplastic anemia undergoing allogeneic bone marrow transplantation. All 4 children engrafted successfully in spite of the number of donors exposed in the previous blood components transfusion. Three of 4 transplanted children have survived for 390 days, 540 days, and 1,235 days respectively. One child died of graft-versus-host disease related sepsis. The actual survival rate was 75% at one year. Further efforts must be aimed at the elimination of graft-versus-host disease and the control of fatal infections.